Global Equine Veterinary Therapeutics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Equine Veterinary Therapeutics Market Research Report 2024
Equine Veterinary Therapeutics refers to the specialized field of veterinary medicine that focuses on the diagnosis, treatment, and management of health issues and injuries in horses. This branch of veterinary science encompasses a wide range of therapeutic interventions, including medical, surgical, and rehabilitative approaches, all aimed at maintaining the health, well-being, and performance of equines. Equine veterinary therapeutics play a crucial role in ensuring the overall health and longevity of horses, whether they are involved in sports and competition or serve as companion animals.
According to Mr Accuracy reports’s new survey, global Equine Veterinary Therapeutics market is projected to reach US$ 2044.9 million in 2029, increasing from US$ 1258 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029.
A significant driver in the Equine Veterinary Therapeutics market is the growing demand for high-quality healthcare and treatment options for horses. As the importance of equines in various sectors, including sports, agriculture, and leisure, continues to rise, there is an increased emphasis on maintaining their health and performance. This drives the demand for innovative veterinary therapeutics, such as advanced medications, surgical techniques, and rehabilitation methods, to address a wide range of equine health issues. One of the key challenges in this market is the cost associated with advanced equine veterinary care. High-end treatments, specialized surgeries, and cutting-edge therapies can be expensive, which may limit access for some horse owners or require substantial investments. Additionally, ensuring the safety and effectiveness of equine therapeutics can be challenging due to the size and unique physiology of horses, requiring specialized expertise and equipment. Regulatory compliance and ensuring the welfare of the animals also pose ongoing challenges in this industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Equine Veterinary Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Boehringer Ingelheim
Merck Animal Health
Zoetis
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Segment by Type
Drugs
Vaccine
Other
Veterinary Hospital
Veterinary Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Equine Veterinary Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Equine Veterinary Therapeutics market is projected to reach US$ 2044.9 million in 2029, increasing from US$ 1258 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029.
A significant driver in the Equine Veterinary Therapeutics market is the growing demand for high-quality healthcare and treatment options for horses. As the importance of equines in various sectors, including sports, agriculture, and leisure, continues to rise, there is an increased emphasis on maintaining their health and performance. This drives the demand for innovative veterinary therapeutics, such as advanced medications, surgical techniques, and rehabilitation methods, to address a wide range of equine health issues. One of the key challenges in this market is the cost associated with advanced equine veterinary care. High-end treatments, specialized surgeries, and cutting-edge therapies can be expensive, which may limit access for some horse owners or require substantial investments. Additionally, ensuring the safety and effectiveness of equine therapeutics can be challenging due to the size and unique physiology of horses, requiring specialized expertise and equipment. Regulatory compliance and ensuring the welfare of the animals also pose ongoing challenges in this industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Equine Veterinary Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Segment by Type
Drugs
Vaccine
Other
Segment by Application
Veterinary Hospital
Veterinary Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Equine Veterinary Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source